Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
10 2022
Historique:
revised: 01 02 2022
received: 15 09 2021
accepted: 17 02 2022
pubmed: 17 3 2022
medline: 21 10 2022
entrez: 16 3 2022
Statut: ppublish

Résumé

With population growth and aging, the number of people with dementia and related disorders will grow substantially in the years ahead, bringing with it significant societal, health-care, and economic challenges. Here, we analyze dementia policies of seven major countries in Asia/Pacific, Europe, and North America to identify opportunities for early actions to mitigate disease burden. We find that most countries are addressing this need by including a specific focus on early action in their national dementia strategies (five of seven countries), implementing public health initiatives for risk reduction, prevention, and early detection and diagnosis (six of seven countries); supporting enabling research for early detection and risk reduction (six of seven countries); and enacting a system for early, regular brain health screening (one of seven). We discuss risks and opportunities for integrating early action policies and conducting additional systematic research to understand the potential benefits and impacts of these policies.

Identifiants

pubmed: 35293672
doi: 10.1002/alz.12655
pmc: PMC9790361
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1993-2002

Informations de copyright

© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Alzheimers Dement. 2011 Nov;7(6):615-21
pubmed: 22055978
Front Digit Health. 2020 Aug 11;2:14
pubmed: 34713027
Alzheimers Dement. 2020 Jul;16(7):1078-1094
pubmed: 32627328
Alzheimers Dement (Amst). 2020 Aug 18;12(1):e12081
pubmed: 32832590
NPJ Digit Med. 2019 Jun 3;2:44
pubmed: 31304390
J Alzheimers Dis. 2015;44(1):195-204
pubmed: 25208621
Dement Neurocogn Disord. 2020 Dec;19(4):125-128
pubmed: 33377665
Alzheimers Dement. 2022 May;18(5):1071-1074
pubmed: 34569686
Rand Health Q. 2019 May 16;8(3):2
pubmed: 31205802
Am J Manag Care. 2020 Aug;26(8 Suppl):S167-S176
pubmed: 32840330
J Glob Health. 2019 Dec;9(2):020320
pubmed: 31893029
Int J Environ Res Public Health. 2019 Oct 11;16(20):
pubmed: 31614513
J Glob Health. 2019 Dec;9(2):020321
pubmed: 31893030
Nature. 2020 Feb;578(7793):S1-S3
pubmed: 32025021
EMBO Mol Med. 2021 Nov 8;13(11):e13659
pubmed: 34633146
Alzheimers Dement (Amst). 2020 Sep 28;12(1):e12109
pubmed: 33015311
Prog Neurobiol. 2019 Oct;181:101662
pubmed: 31351912
J Prev Alzheimers Dis. 2017;4(2):109-115
pubmed: 29071250
Adv Prev Med. 2017;2017:9708413
pubmed: 28932605
Clin Chim Acta. 2021 Aug;519:267-275
pubmed: 34015303
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Alzheimers Dement. 2022 Oct;18(10):1993-2002
pubmed: 35293672

Auteurs

Harald Hampel (H)

Neurology Business Group, Eisai Inc., Nutley, New Jersey, USA.

Andrea Vergallo (A)

Neurology Business Group, Eisai Inc., Nutley, New Jersey, USA.

Takeshi Iwatsubo (T)

University of Tokyo, Tokyo, Japan.

Min Cho (M)

Neurology Business Group, Eisai Inc., Nutley, New Jersey, USA.

Kiyoshi Kurokawa (K)

National Graduate Institute for Policy Studies, Chairman, Health and Global Policy Institute, Tokyo, Japan.

Huali Wang (H)

Peking University Institute of Mental Health (Sixth Hospital), Beijing, China.

H Ricky Kurzman (HR)

Neurology Business Group, Eisai Inc., Nutley, New Jersey, USA.

Christopher Chen (C)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH